The CLEAR Study

The CLEAR Study is a clinical research trial that investigates whether a drug called colesevelam can improve blood sugar control in people with type 2 diabetes who are taking insulin. The study aims to determine if adding colesevelam helps reduce blood sugar levels more effectively than a placebo (a harmless, inactive substance). It also assesses the drug’s safety and any potential side effects. This research helps doctors understand if colesevelam can be a useful additional treatment option for managing diabetes.